普通外文研报
HON: 2026 Guidance Update Abridged Transcript
研报英文原文证据摘录
HON: 2026 Guidance Update Abridged Transcript
ith the most recent funding round at a valuation of $10bn (~$5.2bn attributable to
Implied Cash P/E 28x Honeywell). There could also be ~20c benefit to earnings from a de-consolidation of
Target Price $314 this asset.
Upcoming Investor Events: We view the upcoming June investor events as
Base Case opportunities for management to reinforce the message of accelerated organic
growth from portfolio refinement and upsized investment spending, as well as Organic Growth (CAGR: '23-'25) 5%
margin expansion from Aero OE repricing initiatives, supply chain unlock and Process
OM Expansion ('23-'25) (1.4%)
mix improvement.
Cash EPS 2027e (ex-Pension) $10.92
Pension Surplus Monetization: Honeywell has the potential to monetize a portion of
Surplus Capital 7 its $5.3bn ($8/share) pension plan surplus at YE25.
Implied Cash P/E 25x
Target Price $275
Potential Risks
RemainCo Portfolio Work in Progress: There has been a high degree of acquisitions
Bear Case
and disposals, as management seeks to reposition RemainCo. However, the Industrial
Organic Growth (CAGR: '23-'25) 5%
Automation segment seems subscale and so we view this portfolio surgery as very
OM Expansion ('23-'25) (1.4%) much a work in progress.
Cash EPS 2027e (ex-Pension) $9.86 RemainCo Post-Spin Earnings Noise: Stranded costs resulting from Aero separation
Surplus Capital 7 could be substantial and amount to $400-500m. We would expect these to be
Implied Cash P/E 19x substantially eliminitated by YE27, but it has potential to create friction to RemainCo
Target Price $184 estimates in 2H26.
Pension Income: Honeywell has a substantial contibution from non-cash pension
income, sized at ~8% EPS. This is excluded from our valuation framework but this
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器